Back

Adverse events following transcatheter aortic valve implantation (TAVI) in patients with amyloidosis: observations from a global federated network.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: TAVI: aortic stenosis and beyond Prosthetic Heart Valves ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Luigi Gerra

Guglielmo da Saliceto Hospital, Piacenza (Italy)

5 More presentations in this session

Presentation thumbnail
A propensity score matched analysis of transcatheter aortic valve replacement in failed bioprosthetic valves
Doctor K. Loew (Munich, DE) Professor S. Deseive (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Predictors for mitral regurgitation improvement in patients with pure severe aortic regurgitation undergoing transcatheter aortic valve replacement: when can kill two birds with one stone?
Doctor D. Lin (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of transcatheter aortic valve implantation (TAVI) for pure aortic regurgitation; a systematic review and meta-analysis
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Association of cardiac amyloidosis with periprocedural complications in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis
Doctor T. Figueira (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of aortic stenosis patients with different flow/gradient patterns undergoing transcatheter aortic valve implantation
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI: aortic stenosis and beyond

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Association of cardiac amyloidosis with periprocedural complications in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis
thumbnail
Congress Presentation
Long-term outcomes in patients with dual pathology aortic stenosis and cardiac amyloidosis referred for valve intervention
thumbnail
Congress Presentation
Prognostic significance of concomitant transthyretin cardiac amyloidosis and severe aortic stenosis: insights from a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources